Pediatric Hematology Oncology Journal (Mar 2023)

Successful matched unrelated donor hematopoietic stem cell transplantation for infantile Wolman disease

  • Indira Jayakumar,
  • Anupama Gude,
  • Murarji Renangi,
  • Soundaram Valliyappan,
  • Venkateswaran Vellaichamy Swaminathan,
  • Satishkumar Meena,
  • Harika Varla,
  • Rumesh Chandar,
  • Ramya Uppuluri,
  • Revathi Raj

Journal volume & issue
Vol. 8, no. 1
pp. 1 – 3

Abstract

Read online

Introduction: Wolman disease is a rare genetic disorder with an autosomal recessive inheritance. A mutation in the LIPA gene causes lysosomal acid lipase (LAL) deficiency results in lipid storage and adrenal insufficiency. Death in early infancy is due to liver failure. Patients and methods: We describe the clinical course of a three-month-old infant diagnosed with Wolman disease. A rapid mutational analysis confirmed a LIPA gene defect. Results: He underwent matched unrelated donor peripheral blood stem cell hematopoietic stem cell transplantation (HSCT) at 3 months of age, with a treosulfan-based conditioning, which resulted in engraftment with donor-derived hematopoietic cells. He required supportive care for sinusoidal obstruction syndrome and mucositis. He was administered low dose prednisolone for grade I skin graft versus host disease, and a complete donor chimerism was documented on several occasions. At one year post HSCT, his growth and development were optimal, and there was no hepatosplenomegaly. He is maintained on glucocorticoid and mineralocorticoid supplements for primary hypoaldosteronism. Conclusion: The case emphasizes the timely diagnosis and the potential for successful treatment of Wolman disease by HSCT.

Keywords